Jodas Expoim Pvt. Ltd. is an emerging global pharmaceutical company founded in 2006 in India. With the slogan "One Step Better," the company focuses on specialty, innovation-driven, generic pharmaceuticals. Jodas specializes in core therapeutic segments including Anti Infectives (Injectables), Anti Cancer (Injectables & Orals), Contrast Media – Injectables, and Critical Care (Injectables & Orals). The company's commitment to quality and affordability is evident in its efforts to bring high-quality, effective, and affordable generic formulations to the market, with approved products in 30+ countries. Jodas boasts state-of-the-art manufacturing facilities and has successfully commercialized 19.4 million Injectables in 2022, resulting in unparalleled customer satisfaction. Their vision is to become a global generic player, aiming to fulfill unmet medical needs worldwide with specialty generic formulations of uncompromising quality. Jodas Expoim Pvt. Ltd. operates in the Biopharma, Health Care, and Pharmaceutical industries, positioning itself as a significant player in the global pharmaceutical landscape.
There is no investment information
No recent news or press coverage available for Jodas Expoim Pvt. Ltd..